Johnson & Johnson Innovation - JJDC, Inc. - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 108 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Johnson & Johnson Innovation - JJDC, Inc. ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$4,473,000
-4.6%
394,8340.0%0.46%
-24.8%
Q1 2021$4,691,000
+14.9%
394,834
-33.6%
0.61%
+15.6%
Q4 2020$4,081,000
-7.4%
594,8340.0%0.53%
-40.7%
Q3 2020$4,408,000
+77.7%
594,8340.0%0.89%
+82.1%
Q2 2020$2,480,000
+68.8%
594,8340.0%0.49%
-39.1%
Q1 2020$1,469,000
-57.5%
594,8340.0%0.80%
-35.8%
Q4 2019$3,456,000594,8341.25%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders